Arrhythmogenic cardiomyopathy is a rare genetic disease that is mostly inherited as an autosomal dominant trait. It is associated predominantly with mutations in desmosomal genes and is characterized by the replacement of the ventricular myocardium with fibrous fatty deposits, arrhythmias and a high risk of sudden death. In vitro studies have contributed to our understanding of the pathogenic mechanisms underlying this disease, including its genetic determinants, as well as its cellular, signaling and molecular defects. Here, we review what is currently known about the pathogenesis of arrhythmogenic cardiomyopathy and focus on the in vitro models that have advanced our understanding of the disease. Finally, we assess the potential of established and innovative cell platforms for elucidating unknown aspects of this disease, and for screening new potential therapeutic agents. This appraisal of in vitro models of arrhythmogenic cardiomyopathy highlights the discoveries made about this disease and the uses of these models for future basic and therapeutic research.
Cell models of arrhythmogenic cardiomyopathy: advances and opportunities / E. Sommariva, I. Stadiotti, G.L. Perrucci, C. Tondo, G. Pompilio. - In: DISEASE MODELS & MECHANISMS. - ISSN 1754-8403. - 10:7(2017), pp. 823-835.
|Titolo:||Cell models of arrhythmogenic cardiomyopathy: advances and opportunities|
|Parole Chiave:||ACM; Arrhythmogenic cardiomyopathy; ARVC; Cell models; In vitro; Molecular mechanisms; Neuroscience (miscellaneous); Medicine (miscellaneous); Immunology and Microbiology (miscellaneous); Biochemistry, Genetics and Molecular Biology (all)|
|Settore Scientifico Disciplinare:||Settore MED/11 - Malattie dell'Apparato Cardiovascolare|
|Data di pubblicazione:||2017|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1242/dmm.029363|
|Appare nelle tipologie:||01 - Articolo su periodico|